Risk Factor Analysis of Deep Surgical Site Infection After Posterior Instrumented Fusion Surgery for Spinal Trauma: A Multicenter Observational Study.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 02 08 2019
revised: 18 10 2019
accepted: 19 10 2019
pubmed: 2 11 2019
medline: 17 3 2020
entrez: 1 11 2019
Statut: ppublish

Résumé

Surgical site infection (SSI) is a dire complication in spinal surgeries, resulting in reoperation, prolonged hospitalization, and increased expenses. Patients with traumatized spine have been reported to have a high risk of postoperative SSI. Precise identification of risk factors associated with SSI can be helpful in its prevention. However, there are only a limited number of studies investigating risk factors of SSI after posterior instrumented fusion for traumatized spine. From July 2010 to June 2015, we conducted an observational study on deep SSI after posterior instrumented fusion surgery for spinal trauma in adult patients at 10 research hospitals. Detailed clinical data were prospectively collected using a standardized data collection chart and were retrospectively analyzed. SSI was diagnosed based on the definition by the Centers for Disease Control and Prevention. A total of 623 consecutive adult patients were enrolled in this study, of which 20 (3.2%) developed deep SSI. According to multivariate regression analysis, surgery at academic hospitals (P = 0.004) and an American Society of Anesthesiologists (ASA) score ≥3 (P = 0.017) were independent predictors of deep SSI after posterior instrumented fusion surgery for spinal trauma. The complexity of patients and resident involvement in surgeries may be greater at academic than at nonacademic hospitals. ASA score can be considered as an accessible and comprehensive tool for surgeons to preoperatively gauge the potential risk of SSI, a complex clinical entity. The results of this study can improve clinicians' risk perception in those undergoing posterior fusion for spinal trauma.

Sections du résumé

BACKGROUND BACKGROUND
Surgical site infection (SSI) is a dire complication in spinal surgeries, resulting in reoperation, prolonged hospitalization, and increased expenses. Patients with traumatized spine have been reported to have a high risk of postoperative SSI. Precise identification of risk factors associated with SSI can be helpful in its prevention. However, there are only a limited number of studies investigating risk factors of SSI after posterior instrumented fusion for traumatized spine.
METHODS METHODS
From July 2010 to June 2015, we conducted an observational study on deep SSI after posterior instrumented fusion surgery for spinal trauma in adult patients at 10 research hospitals. Detailed clinical data were prospectively collected using a standardized data collection chart and were retrospectively analyzed. SSI was diagnosed based on the definition by the Centers for Disease Control and Prevention.
RESULTS RESULTS
A total of 623 consecutive adult patients were enrolled in this study, of which 20 (3.2%) developed deep SSI. According to multivariate regression analysis, surgery at academic hospitals (P = 0.004) and an American Society of Anesthesiologists (ASA) score ≥3 (P = 0.017) were independent predictors of deep SSI after posterior instrumented fusion surgery for spinal trauma.
CONCLUSIONS CONCLUSIONS
The complexity of patients and resident involvement in surgeries may be greater at academic than at nonacademic hospitals. ASA score can be considered as an accessible and comprehensive tool for surgeons to preoperatively gauge the potential risk of SSI, a complex clinical entity. The results of this study can improve clinicians' risk perception in those undergoing posterior fusion for spinal trauma.

Identifiants

pubmed: 31669691
pii: S1878-8750(19)32745-7
doi: 10.1016/j.wneu.2019.10.117
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e524-e529

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Satoshi Ogihara (S)

Department of Orthopaedic Surgery, Saitama Medical University, Saitama, Japan. Electronic address: sogihara@saitama-med.ac.jp.

Takashi Yamazaki (T)

Department of Orthopaedic Surgery, Musashino Red Cross Hospital, Tokyo.

Michio Shiibashi (M)

Information Technology Center, Saitama Medical University, Saitama, Japan.

Toru Maruyama (T)

Department of Orthopaedic Surgery, Saitama Rehabilitation Center, Saitama, Japan.

Hirotaka Chikuda (H)

Department of Orthopaedic Surgery, Faculty of Medicine, Gunma University, Gunma, Japan.

Kota Miyoshi (K)

Department of Orthopaedic Surgery, Yokohama Rosai Hospital, Kanagawa, Japan.

Hirohiko Inanami (H)

Department of Orthopaedic Surgery, Iwai Orthopaedic Medical Hospital, Tokyo, Japan.

Yasushi Oshima (Y)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan.

Seiichi Azuma (S)

Department of Orthopaedic Surgery, Saitama Red Cross Hospital, Saitama, Japan.

Naohiro Kawamura (N)

Department of Spine and Orthopaedic Surgery, Japanese Red Cross Medical Center, Tokyo, Japan.

Kiyofumi Yamakawa (K)

Department of Orthopaedic Surgery and Musculoskeletal Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.

Nobuhiro Hara (N)

Department of Orthopaedic Surgery, Musashino Red Cross Hospital, Tokyo.

Jiro Morii (J)

Department of Orthopaedic Surgery, Sanraku Hospital, Tokyo, Japan.

Rentaro Okazaki (R)

Department of Orthopaedic Surgery, Saitama Red Cross Hospital, Saitama, Japan.

Yujiro Takeshita (Y)

Department of Orthopaedic Surgery, Yokohama Rosai Hospital, Kanagawa, Japan.

Kei Sato (K)

Department of Orthopaedic Surgery, Saitama Medical University, Saitama, Japan.

Sakae Tanaka (S)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan.

Kazuo Saita (K)

Department of Orthopaedic Surgery, Saitama Medical University, Saitama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH